ADVERTISEMENT
SEC suggests emergency use authorisation for Jubilant Life Sciences's remdesivir tablets
DH Web Desk
Last Updated IST
Representative image. Credit: iStock Photo
Representative image. Credit: iStock Photo

Central Drugs Standard Control Organization's Subject Expert Committee has suggested emergency use authorisation for Remdesivir tablets by Jubliant life Sciences, according to a report by ANI quoting sources.

More to follow...

ADVERTISEMENT
(Published 27 May 2021, 09:32 IST)